Tritumumab
|
WikiDoc Resources for Tritumumab |
|
Articles |
|---|
|
Most recent articles on Tritumumab |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Tritumumab at Clinical Trials.gov Clinical Trials on Tritumumab at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Tritumumab
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Tritumumab Discussion groups on Tritumumab Patient Handouts on Tritumumab Directions to Hospitals Treating Tritumumab Risk calculators and risk factors for Tritumumab
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Tritumumab |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Tritumumab is a human monoclonal antibody and which it is used to treat cancer.